Who
Vijay Kasturi
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, CG Oncology.
In numbers
- Trades disclosed
- 5
- Buys
- 1
- Sells
- 0
- Bought
- $25K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Jan 2024
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —79,216 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —79,216 at $0.00 | filing |
| 15 Apr 2025filed 16 Apr 2025 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —203,868 at $0.00 | filing |
| 4 Oct 2024filed 7 Oct 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —132,600 at $0.00 | filing |
| 29 Jan 2024filed 31 Jan 2024 | CGON CG OncologyBiotechnology | SEC FORM 4 Bought | $25K1,315 at $19.00 | filing |
News
Head to Head Contrast: CG Oncology (NASDAQ:CGON) and Myriad Genetics (NASDAQ:MYGN)CGON · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Vijay Kasturi; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.